We have previously reported that in patients starting on dialysis circulating pentosidine correlated with biomarkers of inflammation and malnutrition, but not with all-cause mortality [6], while, in HD patients, IL-6 was found to be a better predictor of mortality than pentosidine and other oxidative stress and inflammatory biomarkers [34]. This evidence concerns the gene IL6 and Huntington disease.